Boosting Therapeutic Substitution Rests With Physician Education, HHS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Issue brief by the Office of the Assistant Secretary for Planning and Evaluation cites cost-savings potential of increasing substitution of brand drugs with generics that are not therapeutically equivalent but carry the same indication.